Curaleaf International part of Curaleaf Holdings (OTCQX:CURLF) (CSE:CURA) successfully registered the company’s cannabis based medicines as extract in Poland, with local partner CanPoland S.A.

Commenting on this landmark registration, Curaleaf International president Miles Worne stated: “This license in Poland is another sign of Curaleaf International’s strong momentum in Europe. The medical cannabis market in Europe continues to expand rapidly, as regulation opens up and access for patients improves. Since the legalization of medical cannabis in 2017, Poland has become one of the largest European importers of dried flower and is an excellent addition to Curaleaf International’s expansion, given its fast-growing patient numbers and significant addressable market. Curaleaf International is driving growth in existing key markets, with the UK in particular witnessing a huge increase in patient numbers, whilst continuing to drive expansion into new markets across Europe.”